Amphastar said its imported heparin product presents "no threat whatsoever to the drug-consuming public" because that heparin is not intended for consumers. It is to be used for its generic Lovenox application, the company said.
Hmmm, seems like a company gaffe to me. "We were going to use that potentially contaminated ingredient for our FDA application. It wasn't intended for the public...at least not yet...".
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.